Aboleris Pharma
5 known investors
Find your way into Aboleris Pharma
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
Founders & leadership
Investors · 5
Frequently asked questions
- What does Aboleris Pharma do?
- AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.
- Who founded Aboleris Pharma?
- Aboleris Pharma was founded by Ignacio Anegon, Carole Guillonneau, François-Xavier Hubert.
- Who are Aboleris Pharma's investors?
- Aboleris Pharma's investors include Criteria Bio Ventures, Newton Biocapital, Sound Bioventures, Sambrinvest, Wallonie Entreprendre.